suberoyl bis-hydroxamic acid has been researched along with Diabetes Mellitus, Type 2 in 1 studies
suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poddar, S | 1 |
| Kesharwani, D | 1 |
| Datta, M | 1 |
1 other study available for suberoyl bis-hydroxamic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Histone deacetylase inhibition regulates miR-449a levels in skeletal muscle cells.
Topics: Aged; Animals; Case-Control Studies; Cdc20 Proteins; Cell Line; Diabetes Mellitus, Type 2; Epigenesi | 2016 |